Marketed under the trade name Latuda®, Lurasidone is a new atypical antipsychotic developed for the treatment of schizophrenia. This stable-labeled internal standard is suitable for use in LC/MS or GC/MS applications including clinical toxicology, forensic testing, or pharmaceutical research.
CERILLIANT is a registered trademark of Cerilliant Corporation
Latuda is a registered trademark of Dainippon Sumitomo Pharma Co., Ltd.
Snap-N-Spike is a registered trademark of Cerilliant Corporation